go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

MSD Ireland (Human Health) Limited

MSD Ireland (Human Health) Limited
Pelham House, South County Business Park, Leopardstown, Dublin 18, Ireland
Telephone: +353 1 299 8700
Fax: +353 1 299 8701
Medical Information e-mail: medinfo_ireland@merck.com
Patient Information Leaflet last updated on medicines.ie: 17/01/2012
PIL FOSAVANCE 70mg/2800 IU Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 17/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to further information section
Updated on 07/10/2011 and displayed until 17/01/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 30/06/2011 and displayed until 07/10/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 17/02/2011 and displayed until 30/06/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 05/10/2010 and displayed until 17/02/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to date of revision
Updated on 09/06/2010 and displayed until 05/10/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 18/01/2010 and displayed until 09/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 27/08/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 18/12/2008 and displayed until 27/08/2009
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 05/09/2008 and displayed until 18/12/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 31/07/2008 and displayed until 05/09/2008
Reasons for adding or updating:
  • Change to marketing authorisation holder address
Updated on 03/01/2008 and displayed until 31/07/2008
Reasons for adding or updating:
  • Change of trade or active ingredient name
  • Change to warnings or special precautions for use
Updated on 17/05/2007 and displayed until 03/01/2008
Reasons for adding or updating:
  • Change to improve clarity and readability
  • Change to side-effects
  • Change to drug interactions
Updated on 30/09/2005 and displayed until 17/05/2007
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Colecalciferol (Vitamin D3)
   Alendronate Sodium Trihydrate

Versions

 
17/01/2012 to Current
07/10/2011 to 17/01/2012
30/06/2011 to 07/10/2011
17/02/2011 to 30/06/2011
05/10/2010 to 17/02/2011
09/06/2010 to 05/10/2010
18/01/2010 to 09/06/2010
27/08/2009 to 18/01/2010
18/12/2008 to 27/08/2009
05/09/2008 to 18/12/2008
31/07/2008 to 05/09/2008
03/01/2008 to 31/07/2008
17/05/2007 to 03/01/2008
30/09/2005 to 17/05/2007
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo